Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries.

ABSTRACT:

Background

In a number of malaria endemic regions, tourists and travellers face a declining risk of travel associated malaria, in part due to successful malaria control. Many millions of visitors to these regions are recommended, via national and international policy, to use chemoprophylaxis which has a well recognized morbidity profile. To evaluate whether current malaria chemo-prophylactic policy for travellers is cost effective when adjusted for endemic transmission risk and duration of exposure. a framework, based on partial cost-benefit analysis was used.

Methods

Using a three component model combining a probability component, a cost component and a malaria risk component, the study estimated health costs avoided through use of chemoprophylaxis and costs of disease prev

SUBMITTER: Massad E 

PROVIDER: S-EPMC3123601 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature